0000950170-24-023374.txt : 20240229 0000950170-24-023374.hdr.sgml : 20240229 20240229183413 ACCESSION NUMBER: 0000950170-24-023374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240227 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saad Mark E CENTRAL INDEX KEY: 0001295913 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 24705990 BUSINESS ADDRESS: BUSINESS PHONE: 858-458-0900 MAIL ADDRESS: STREET 1: C/O CYTORI THERAPEUTICS, INC. STREET 2: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 ownership.xml 4 X0508 4 2024-02-27 0001579428 Axsome Therapeutics, Inc. AXSM 0001295913 Saad Mark E C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 true false false false false Stock Option (Right to Buy) 84.00 2024-02-27 4 A false 1519 0.00 A 2024-02-27 2034-02-26 Common Stock 1519 1519 D Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable. /s/ Herriot Tabuteau, M.D., Attorney in Fact 2024-02-29